Tim Hodson, Contributing Editor

Submitted by wainscot on Mon, 11/07/2022 - 10:18

Nov. 4, 2022 — Guerbet announced an agreement with Merative formalizing the termination of their collaboration initiated in July 2018. This partnership aimed to design, develop and market software solutions to help diagnose and monitor liver and prostate cancers.

Nov. 4, 2022 — The U.S. Food and Drug Administration (FDA) is recommending health care providers discuss alternative options for Magnetic Resonance Imaging (MRI)-guided breast biopsy procedures with patients if a facility is unable to perform the biopsy due to a shortage of Philips Invivo MRI breast biopsy grid plates and other Philips Invivo MRI disposables.

The FDA Recommends That Health Care Providers:

·      Discuss options with patients if MRI breast biopsy grid plates or other MRI coil disposables are not available at their facility.


Leading into the last part of the year inevitably includes discussions around RSNA. One of the common threads of discussion is related to technology and its replacement, procurement and ultimately adoption.



Patients are the motivational driver for innovation in breast imaging companies. Their needs and experiences help determine where medical technology is headed, as companies explore how to make the pathways from screening to diagnosis and treatment easier and more efficient.


November 3, 2022 — Hologic, Inc., a global leader in women’s health, announced that its 3Dimensions mammography system was awarded EUREF Type Test certification by the European Reference Organisation for Quality Assured Breast Screening and Diagnostic Services (

November 3, 2022 — Konica Minolta Healthcare Americas, Inc., a leader in medical diagnostic imaging and healthcare information technology, announces the introduction of new digital radiography (DR) solutions that will continue to transform the clinical value of X-ray.

November 3, 2022 — Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that it is developing the MEVION S250-FIT Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS).

Subscribe Now